InvestorsHub Logo
Followers 10
Posts 1244
Boards Moderated 0
Alias Born 10/12/2012

Re: None

Tuesday, 12/29/2015 9:34:48 PM

Tuesday, December 29, 2015 9:34:48 PM

Post# of 30990
Berberine---may be worth looking at. Another natural ingredients big Pharma doesn't want you to know about. ~Has reduced my pre-diabetic blood sugar from the 120 to 140 range to below 100 after 4 weeks dosing at 400 mg/3 x day, before meals.

Excerpt from Wikipedia:
"Diabetes, dyslipidemias and cardiovascular conditions[edit]
During the last few decades, many studies have shown berberine has various beneficial effects on the cardiovascular system and significant anti-inflammatory activities.[19]
A Canadian report suggested berberine can effectively reduce intracellular superoxide levels in LPS-stimulated macrophages. Such a restoration of cellular redox by berberine is mediated by its selective inhibition of gp91phox expression and enhancement of SOD activity.[20]
Berberine exerts up-regulating activity on both the low-density-lipoprotein receptor (LDLR) and the insulin receptor (InsR). This one-drug-multiple-target characteristic might be suitable for the treatment of metabolic syndrome.[21][22]
Diabetes mellitus[edit]
Berberine has been tested and used successfully in experimental[23][24] and human diabetes mellitus.[25][26][27][28]
Berberine has been shown to lower elevated blood glucose as effectively as metformin.[29] The mechanisms of action include inhibition of aldose reductase,[30] inducing glycolysis,[31] preventing insulin resistance[32][33] through increasing insulin receptor expression[26] and acting like incretins.[34] A new study suggested berberine may overcome insulin resistance via modulating key molecules in insulin signaling pathway, leading to increased glucose uptake in insulin-resistant cells.[35]

Berberine might exert its insulinotropic effect in isolated rat islets by up-regulating the expression of hepatocyte nuclear factor 4 alpha, which probably acts solely or together with other HNFs to modulate glucokinase activity, rendering ß cells more sensitive to glucose fluctuation and to respond more effectively to glucose challenge.[36]
Berberine seems to inhibit human dipeptidyl peptidase-4 (DPP4), as well as the prodiabetic target human protein tyrosine phosphatase 1B (h-PTP 1B), which explain at least some of its antihyperglycemic activities.[37] Berberine suppresses intestinal disaccharidases with beneficial metabolic effects in diabetic states.[38]
A recent comprehensive metabolomics method, applied to 60 type 2 diabetics, suggested administration of berberine down-regulates the high level of free fatty acids which are known to be toxic to the pancreas and cause insulin resistance. These results suggest berberine might play a pivotal role in the treatment of type 2 diabetes, concluded the authors.[25]

Berberine has been shown to boost the effects of metformin and 2,4-thiazolidinedione (TZD), and can partly replace the commercial drugs, which could lead to a reduction in toxicity and side effects of the latter.[39]
Berberine inhibits FOXO1,[40] which integrates insulin signaling with mitochondrial function. Inhibition of Foxo1 can improve hepatic metabolism during insulin resistance and the metabolic syndrome.[41]"

"Cancer[edit]
Berberine has drawn extensive attention towards its antineoplastic effects.[64][65] It seems to suppress the growth of a wide variety of tumor cells, including breast cancer,[66] leukemia, melanoma,[67] epidermoid carcinoma, hepatoma, pancreatic cancer,[68] oral carcinoma, tongue carcinoma,[69] glioblastoma, prostate carcinoma and gastric carcinoma.[70][71] Animal studies have shown that berberine can suppress chemical-induced carcinogenesis, clastogenesis,[72] tumor promotion, tumor invasion,[73][74][75][76][77] prostate cancer,[78][79][80][81] neuroblastoma,[82][83] and leukemia.[49][84]
It is a radiosensitizer of tumor cells, but not of normal cells. How berberine mediates these effects is not fully understood, but its ability to inhibit angiogenesis and to modulate Mcl-1, Bcl-xL, cyclooxygenase (COX)-2, MDR, tumor necrosis factor (TNF)- and IL-6, iNOS, IL-12, intercellular adhesion molecule-1 and ELAM-1 expression, MCP-1 and CINC-1, cyclin D1,[85] activator protein (AP-1), HIF-1, PPAR-, and topoisomerase II has been shown. By using yeast mutants, berberine was found to bind and inhibit stress-induced mitogen-activated protein kinase kinase activation. Because apoptotic, carcinogenic, and inflammatory effects and various gene products (such as TNF-a, IL-6, COX-2, adhesion molecules, cyclin D1, and MDR) modulated by berberine are regulated by the transcription factor nuclear factor- B (NF- B), it is postulated this pathway plays a major role in the action of berberine.[86] Berberine suppressed NF-?B activation induced by various inflammatory agents and carcinogens. This alkaloid also suppressed constitutive NF-?B activation found in certain tumor cells. It seems to protect against side effects of radiation therapy in lung cancer.[87] However, new studies suggest that while berberine decreases cell growth, it increases the side population (stem cell) fraction of H460 lung cancer cells.[88] In lung cancer it can also act through suppression of TGF-ß1-induced epithelial-to-mesenchymal transition.[89] Berberine enhances chemosensitivity to some chemotherapeutic agents like irinotecan .[90]"

Article at:
https://en.wikipedia.org/wiki/Berberine

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.